Cargando…
A novel immunosuppression-based classification of liver tumors opens new perspectives for adapted therapeutic strategies
Autores principales: | Bévant, Kevin, Coulouarn, Cédric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136603/ https://www.ncbi.nlm.nih.gov/pubmed/32268278 http://dx.doi.org/10.1016/j.ebiom.2020.102737 |
Ejemplares similares
-
A Minimal Subset of Seven Genes Associated with Tumor Hepatocyte Differentiation Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
por: Desoteux, Matthis, et al.
Publicado: (2021) -
Transcriptomic evidence for tumor‐specific beneficial or adverse effects of TGFβ pathway inhibition on the prognosis of patients with liver cancer
por: Desoteux, Matthis, et al.
Publicado: (2023) -
DNA Methylation of TGFβ Target Genes: Epigenetic Control of TGFβ Functional Duality in Liver Cancer
por: Bévant, Kevin, et al.
Publicado: (2021) -
TGFβ‐induced FOXS1 controls epithelial–mesenchymal transition and predicts a poor prognosis in liver cancer
por: Bévant, Kevin, et al.
Publicado: (2021) -
Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies
por: Park, Kevin, et al.
Publicado: (2022)